Filter Results:
(994)
Show Results For
- All HBS Web
(994)
- People (4)
- News (257)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Show Results For
- All HBS Web
(994)
- People (4)
- News (257)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
- 01 Dec 2013
- News
Your Own Medicine
drug he has ever taken that directly targets his DMD, a rare degenerative disorder in boys that weakens the body's muscles, usually putting sufferers in wheelchairs in adolescence and shutting down their heart and lungs in their 20s. For... View Details
- 01 Sep 2004
- News
Bill Dunaway (MBA 1964)
A self-described SOB — son of the boss — Bill Dunaway grew up working in his father’s pharmacy in Marietta, Georgia, a town of 61,000 outside Atlanta. After expanding the business to a chain of 18 drug stores, Dunaway sold the operation... View Details
- 31 Oct 2004
- Research & Ideas
Bypass Marketing: Are Docs Influenced?
Until the close of the last decade, health consumers received much of their knowledge and advice about prescription drugs from their physicians or other health care professionals. Today, pharmaceutical companies are spending several... View Details
Keywords: by Manda Salls
- 18 Jul 2024
- Blog Post
Harvard Business School Announces Its 2024-2025 Blavatnik Fellows
immune system-driven dendritic cell therapy to combat cancer, new molecular technologies for the delivery of transdermal formulations, a lipid-targeting drug to treat cancer and neurodegenerative disorders, and AI-driven medical... View Details
- 15 Dec 2024
- News
After Ozempic
Back before Ozempic, when Kate Mulroney (MBA 1984) spoke at technical conferences about her work at Novo Nordisk, people often assumed she was talking about Novartis. “I’d have to explain that’s a Swiss company; we’re Danish,” says Mulroney, now head of advanced... View Details
Melvin R. Goodes
Goodes grew Warner-Lambert’s market value from $9 billion in 1991 to almost $60 billion in 1999. He helped the pharmaceutical company become a major player in the prescription drug industry and is responsible for striking a deal with... View Details
Keywords: Personal Care & Home Products
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
wants to understand the barriers to effecting change on global issues such as health care." Under Ray Gilmartin's leadership, Merck has launched an unprecedented number of new drugs and forged partnerships with the public and nonprofit... View Details
- 09 Aug 2016
- First Look
August 9, 2016
https://www.hbs.edu/faculty/Pages/item.aspx?num=51304 The Impact of the Entry of Biosimilars: Evidence from Europe By: Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologic drugs (therapeutic proteins or... View Details
Keywords: Sean Silverthorne
- 01 Jun 2012
- News
The Power of Philanthropy
announced its approval of Kalydeco, a drug produced by Vertex that will immediately help some 1,200 cystic fibrosis patients and is viewed as a breakthrough precursor drug to forthcoming products that will... View Details
Thomas M. Rauch
Through significant investments in research and development, Rauch enabled Smith Kline to build a pipeline of new products and drug applications. During his leadership, Smith Kline’s revenues increased from $259 million to $357 million –... View Details
Keywords: Healthcare
John W. Culligan
Culligan capped off a 49-year career with American Home Products as its CEO from 1981 to 1986. During his tenure he doubled AHP’s research & development budget, building a pipeline of 24 new drugs and 48 new View Details
Keywords: Healthcare
- Web
Eva Cai | MBA
Eva Cai Bioengineering (SB) Quincy 2021 Cohort 3 As a perpetual learner and bioengineer, I am excited to explore how business perspectives can shape and improve the effectiveness of engineering solutions. Tech areas of interest: Drug... View Details
Stanley P. Goldstein
In 1969, Goldstein’s drug store chain, CVS, was acquired by Melville Corporation and soon became the conglomerate’s dominant retail establishment. Goldstein took the reins of Melville in 1987 and began a total restructuring program... View Details
Keywords: Retail
- 01 Sep 2008
- News
Mara Aspinall
higher efficacy rate — 80 percent or more. Is 80 percent efficacy unusual for drugs currently on the market? Across all patients and diseases, drug efficacy averages 50 percent, so half the time they bring... View Details
- 01 Jun 2000
- News
The Business of Biotech
biotechnology. The prospect is exhilarating, but the road to this brave new biotech world has more than a few bumps. With an average time line of ten years required to bring a drug to market - and the potential for failure looming every... View Details
Keywords: Julia Hanna
- 20 Aug 2014
- News
With No Time to Lose
into ALS research, and removed some critical barriers to the development of treatments. “Our focus, from the start, was to get drug companies to invest money in ALS,” says Kremer, who was diagnosed with the disease in 2004, just weeks... View Details
Keywords: Margie Kelley
- Fast Answer
Pharmaceuticals: Company Data and Analysis
not only information on pharma companies, but also covers drug pipelines and global trials, pharma deals, drug sales, and patents. Access is available to HBS AND HU students, staff and faculty onsite at... View Details
- Fast Answer
Biotech and Pharmaceuticals: R&D spending, production cost
can be found in company’s income statement that can be found in Capital IQ ABI/ProQuest - To locate articles on the topic, use search terms: drug development cost (drug development) AND (success rates) View Details
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
Cambridge, Massachusetts, and you will likely be administered beta blockers, a class of drug that's generally recommended after a heart attack. The rate at which that drug is delivered nationwide, however,... View Details
- 01 Mar 2012
- News
How to Close the Health Gap
the efforts of scientists, health organizations, businesses, and philanthropists to extend the frontiers of medicine and in particular the science of genomics beyond the Northern Hemisphere and into rural villages the world over. It turns out to be a particularly... View Details